Question 1

What is Aptevo Therapeutics?

Accepted Answer

Aptevo Therapeutics is a Company.

Question 2

How often does Aptevo Therapeutics appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Aptevo Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on May 28, 2026.

Question 4

When was Aptevo Therapeutics last mentioned in news?

Accepted Answer

Last active on May 28, 2026.

Question 5

What is Aptevo Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 40 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Aptevo Therapeutics in global news coverage?

Accepted Answer

Attention score of 2, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Aptevo Therapeutics?

Accepted Answer

Aptevo Therapeutics appoints Mary Janatpour (May 28, 2026, 6 articles).

Question 8

How did the "Aptevo Therapeutics appoints Mary Janatpour" event impact Aptevo Therapeutics?

Accepted Answer

Aptevo Therapeutics appointed Mary J. Janatpour>>> as Senior Vice President & Chief Scientific Officer, which is expected to strengthen its oncology pipeline and radiopharmaceutical development strategy.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.